There is increasing concern amongst anaesthetists regarding parenteral viral transmission during the perioperative period, particularly of the human immunodeficiency virus and hepatitis B virus 1 . However other methods of viral transmission can occur. We report a case of adenovirus transmission from patient to doctor by respiratory aerosol, during emergency intubation. While hazards to the patient of tracheal intubation have been well described 2 , hazards to the operator have not been previously reported.
CASE HISTORY
A four-month-old female infant was admitted to hospital following a four-day history of fever, wheeze, cough and poor feeding. On examination she had moderate respiratory distress and an arterial oxygen saturation between 90-94% breathing room air. A clinical diagnosis of bronchiolitis was made. Initial therapy consisted of oxygen 0.5 l/min via nasal cannulae, nebulized salbutamol and intravenous amoxycillin. Over the next 48 hours there was a gradual deterioration in her clinical state, with increasing tachypnoea and oxygen desaturation. The patient was transferred to the paediatric intensive care unit (PICU) where she continued to deteriorate with increasing tachypnoea, thoracic hyperinflation and progressive desaturation below 90% despite FiO 2 >0.6. Periodic bouts of coughing were associated with arterial oxygen desaturation below 50%. As preparations for ventilation were being made the child suffered an acute respiratory arrest with severe bradycardia. She was rapidly intubated by one of the authors (DAS) without the use of drugs. As the tracheal tube passed through the vocal cords the patient coughed through the tube, into the right eye of the operator.
Unfortunately the patient had a protracted and stormy course in the PICU with the development of obliterative bronchiolitis associated with cavitation and multiple pneumothoraces. She developed multisystem organ failure and died 28 days after admission. Eight days after intubation the operator developed signs and symptoms of acute conjunctivitis in the right eye with thickening and injection of the conjuctiva, grittiness, mild photophobia and epiphora. Three days later the inflammation became bilateral. This was followed by the development of systemic influenza-like symptoms with fever, mylagia, and severe pharyngitis. Clinical symptoms persisted for twelve days. During this time the operator took sick leave to minimize risk to other patients and staff.
During the acute phase of the infant's illness, multiple cultures were taken from blood, urine, sputum, faeces and vascular access lines. Nasopharyngeal aspirates were taken for virology. Six days following the development of respiratory symptoms in the infant, adenovirus was identified by direct immuno-fluorescence of nasopharyngeal aspirates (Imagen respiratory virus reagent, Dako Diagnostics, Cambridgeshire, England). Adenovirus was also grown in HEp-2 cell cultures from the same samples. This isolate was identified as type 14 by cell culture neutralization using type-specific antisera (National Institute of Allergy and Infectious Disease, National Institute of Health, Maryland, U.S.A.). Viral swabs from the oropharynx, nasopharynx and conjuctiva of the right eye were taken from the operator. All sites were positive on immunofluorescence for adenovirus and further characterized by cell culture neutralization as also being type 14.
DISCUSSION
Adenoviruses are a common source of infection in semi-closed populations such as hospitals and the military and occur as both epidemics and sporadic infections 3 . Three clinical syndromes have been described: acute respiratory disease, keratoconjunctivitis and pharyngoconjunctival fever. Pharyngoconjunctival fever is associated with general malaise, sore throat and non-ulcerating conjunctivitis 3 . Adenovirus pneumonia can also occur but is much less common, occurring in infants and immunocompromized patients. Very rarely it can progress to widespread obliterative bronchiolitis causing catastrophic pulmonary destruction and death, as in this case 4 . Certain serotypes are typically associated with large outbreaks of illness; for instance type 8 with epidemic keratoconjunctivitis 5 and type 3 with pharyngoconjunctival fever 6 . Two outbreaks of adenovirus type 21 causing bronchopneumonia and pulmonary destruction have been previously reported from this institution 7, 8 . Adenovirus type 14 is not a common source of infection but has been described as a cause of acute respiratory disease 9 and pharyngoconjunctival fever 10 (as seen in the operator). It is important to realise, however, that most of the 41 serotypes have been associated with sporadic disease and no fixed patterns occur.
Adenoviruses are easily transmitted by several means. Along with varicella and influenza viruses, adenoviruses are known to form particle aerosols which can travel two metres or more 11 . Hand carriage or direct contact with virus contaminated secretions are also key mechanisms and probably the most important in hospital-acquired infections 3 . In contrast the mode of transmission in early life is primarily faecal-oral 12 .
Nosocomial transmission of adenovirus is well recognized and a large outbreak of serotype 3 amongst hospital staff from an immunocompromised patient has been previously reported 13 . This is, however, to our knowledge the first time direct inoculation from patient to doctor during tracheal intubation has been described. The coughing of the infant into the unprotected eye of the operator strongly suggests direct aerosol spray as the mode of transmission. It is, however, possible that indirect hand-eye transmission occurred: due to the urgent nature of the procedure, gloves were not worn during intubation although handwashing occurred immediately afterwards.
To minimize the risk of nosocomial infection, Lynch and co-workers have introduced the concept of body substance isolation 14 . This system involves avoiding contact with all body fluids and secretions by barrier protection (as distinct from universal precautions which applies only to serum-derived fluids). Such a system involves the wearing of gloves and handwashing for anticipated contact with blood, secretions, mucous membranes, non-intact skin and moist surfaces of all patients. If secretions or fluids are expected to contact the body or face, then gowns, masks and eye protection should be worn. Appropriate use of these guidelines would have, in all likelihood, prevented cross-infection in this case.
At a time of increasing concern amongst anaesthetists about the risk of parenteral exposure to viruses, this case serves as an important reminder of the possibility of transmission by respiratory aerosols. We suggest that during tracheal intubation of patients with active respiratory disease, the use of body substance isolation is appropriate.
